Global Pericarditis Drugs Market Size, Share & Forecast 2026-2034

добавлена новая статья Health

2026-10-26 13:26:44 -

Worldwide, pericarditis treatment is shifting from broad anti-inflammatory drugs toward targeted IL-1 inhibitors. Recurrent disease is the main area of unmet need, particularly in patients who fail colchicine or depend on steroids. North America dominates because of early approvals and strong reimbursement. Other regions are expected to follow as access widens. According to The Insight...

0 Комментарии 0 Поделились 28 Просмотры 0 предпросмотр